Gabapentin Alternatives in Delaware
Compare generic and therapeutic alternatives to Gabapentin (gabapentin) available at Delaware pharmacies. Save up to 88% on your prescription — no insurance required.
Top Alternatives in Delaware
Pregabalin (generic Lyrica)
therapeutic
Successor to gabapentin — more predictable absorption, slightly higher cost
Avg cash price: $40/mo
Duloxetine (generic Cymbalta)
therapeutic
SNRI effective for neuropathic pain — different mechanism
Avg cash price: $20/mo
Neurontin (brand gabapentin)
brand
Brand name — identical drug at 40× the cost
Avg cash price: $400/mo
Delaware Prescription Assistance Programs
DPAP (Delaware Prescription Assistance Program)
Prescription drug cost-sharing assistance for low-income elderly Delaware residents not fully covered by Medicare Part D.
Eligibility: Delaware residents aged 65+ enrolled in Medicare Part D with income at or below 200% of the federal poverty level.
Frequently Asked Questions
Is gabapentin the same as Neurontin?
Yes — gabapentin is the generic name for Neurontin. It has been generic since 2004 and costs $8–$14/month. Brand Neurontin can exceed $400/month.
Is gabapentin a controlled substance?
Gabapentin is not federally scheduled as a controlled substance in the US, but several states classify it as Schedule V due to misuse potential. Check your state's regulations.
How does gabapentin compare to pregabalin for nerve pain?
Pregabalin (Lyrica) has more predictable and complete absorption than gabapentin. Both are effective for neuropathic pain; gabapentin is much cheaper. Your doctor may start with gabapentin and switch if needed.
Can gabapentin be used for anxiety?
Gabapentin is prescribed off-label for social anxiety disorder and generalised anxiety, particularly in patients who have not responded to SSRIs. This is not an FDA-approved indication.
What does gabapentin cost through Script Unlock?
Gabapentin is among the most affordable medications — typically $8–$14/month. Script Unlock pharmacies can offer competitive cash pricing even at this already-low baseline.